WallStreetZenWallStreetZen
Analyst Ranking
Bottom 13%
#4040 out of 4631 analysts
Average Return
-1.48%
Win Rate
40%23 out of 57
Risk vs Reward
Poor
Good

Paul Matteis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neurogene IncNGNE
+84.14%$22.95$42.26
2024-01-05 -
2024-07-19
Strong Buy
Gw Pharmaceuticals PLCGWPH
+64.79%$98.51$162.33
2017-10-02 -
2018-10-02
Buy
Neurocrine Biosciences IncNBIX
+59.15%$72.78$115.83
2017-11-02 -
2018-11-02
Buy
Dyne Therapeutics IncDYN
+54.85%$26.78$41.47
2024-03-06 -
2024-07-19
Strong Buy
Avadel Pharmaceuticals PLCAVDL
+53.86%$6.35$9.77
2020-03-11 -
2021-03-12
Strong Buy

Paul Matteis Analyst Color

Get additional color on Paul Matteis's coverage of popular stocks

Paul Matteis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Rapport Therapeutics IncRAPP
1Strong Buy$35.00+73.96%Initiates Coverage On
21 days ago
Ionis Pharmaceuticals IncIONS
4Hold$53.00+10.83%Maintains
25 days ago
Alnylam Pharmaceuticals IncALNY
7Strong Buy$295.00+24.04%Maintains
25 days ago
Acadia Pharmaceuticals IncACAD
5Hold$21.00+18.31%Maintains
2 months ago
Denali Therapeutics IncDNLI
2Hold$22.00+2.52%Maintains
2 months ago
Contineum Therapeutics IncCTNM
1Strong Buy$29.00+43.92%Initiates Coverage On
3 months ago
Alto Neuroscience IncANRO
2Strong Buy$32.00+113.48%Reiterates
4 months ago
Dyne Therapeutics IncDYN
2Strong Buy$41.00-1.13%Maintains
5 months ago
Neurogene IncNGNE
1Strong Buy$31.00-26.64%Initiates Coverage On
7 months ago
Biomarin Pharmaceutical IncBMRN
5Strong Buy$101.00+20.11%Reiterates
7 months ago
Sage Therapeutics IncSAGE
4Hold$20.00+62.73%Maintains
7 months ago
Neurocrine Biosciences IncNBIX
5Strong Buy$144.00-1.16%Maintains
7 months ago
Biogen IncBIIB
6Strong Buy$287.00+26.77%Maintains
7 months ago
Alector IncALEC
4Strong Buy$15.00+157.29%Upgrades
7 months ago
Lexeo Therapeutics IncLXEO
1Strong Buy$20.00+78.73%Initiates Coverage On
8 months ago
Vertex Pharmaceuticals IncVRTX
12Hold$373.00-24.12%Reiterates
8 months ago
Vistagen Therapeutics IncVTGN
1Strong Buy$12.00+227.87%Initiates Coverage On
8 months ago
Neumora Therapeutics IncNMRA
1Strong Buy$26.00+130.50%Initiates Coverage On
9 months ago
Pepgen IncPEPG
2Strong Buy$24.00N/AReiterates
a year ago
Alkermes PLCALKS
4Hold$33.00N/AMaintains
a year ago
Karuna Therapeutics IncKRTX
3Strong Buy$295.00N/AMaintains
2 years ago
Cerevel Therapeutics Holdings IncCERE
2Strong Buy$54.00N/AMaintains
2 years ago
Athira Pharma IncATHA
2Hold$5.00N/ADowngrades
2 years ago
Kalvista Pharmaceuticals IncKALV
1Strong Buy$32.00N/AMaintains
2 years ago
Vigil Neuroscience IncVIGL
1Strong Buy$24.00N/AInitiates Coverage On
2 years ago
Eliem Therapeutics IncELYM
1Strong Buy$35.00N/AInitiates Coverage On
3 years ago
Acumen Pharmaceuticals IncABOS
1Strong Buy$27.00N/AInitiates Coverage On
3 years ago
Gh Research PLCGHRS
1Strong Buy$26.00N/AInitiates Coverage On
3 years ago
Prevail Therapeutics IncPRVL
1Strong Buy$23.00N/AInitiates Coverage On
4 years ago
Gw Pharmaceuticals PLCGWPH
4Hold$140.00N/ADowngrades
4 years ago
Avadel Pharmaceuticals PLCAVDL
1Strong Buy$14.00N/AInitiates Coverage On
4 years ago
Zogenix IncZGNX
3Buy$60.00N/AInitiates Coverage On
6 years ago
Acorda Therapeutics IncACORQ
1Hold$2,280.00N/AMaintains
6 years ago
Akcea Therapeutics IncAKCA
2Hold$31.00N/AMaintains
6 years ago
Obseva SaOBSVF
1Buy$18.00N/AMaintains
6 years ago
Wave Life Sciences LtdWVE
1Buy$64.00N/AMaintains
6 years ago
Cidara Therapeutics IncCDTX
1Buy$340.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.